Trial Profile
B Cell Targeted Induction to Improve Outcomes in Pediatric Lung Transplantation (CTOTC-08)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Oct 2021
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Antithymocyte globulin; Corticosteroids; Mycophenolate sodium; Tacrolimus
- Indications Lung transplant rejection
- Focus Therapeutic Use
- 01 Oct 2021 Results published in the American Journal of Transplantation
- 22 Mar 2021 Results of assessment of a remote intervention targeting immunosuppressant management in pediatric lung transplant recipientspublished in the American Journal of Transplantation
- 15 Aug 2019 Status changed from active, no longer recruiting to completed.